---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058622"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:33:23.431480+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Carisma Therapeutics secures Nasdaq listing extension with transfer to Capital Market, strict conditions to Oct 7, 2025

## Summary
- Nasdaq Panel granted exception; listing transferred to Nasdaq Capital Market effective June 12, 2025.
- Must demonstrate closing bid price ≥$1.00 for 10 consecutive sessions by Oct 7, 2025.
- Must complete a strategic transaction and meet all initial listing requirements for Capital Market by Oct 7.
- Company had previously failed MVLS ($50M), MVPHS ($15M), and Bid Price ($1.00) rules.
- Panel may reconsider if conditions not met; no assurance of compliance.

## SEC filing metadata
- accession: 0001104659-25-058622
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465925058622/0001104659-25-058622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465925058622/tm2517769d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058622
- JSON: https://secwatch.observer/filing/0001104659-25-058622.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058622.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.